drugset / Trial / NCT06040476

Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke (AIS)

NCT06040476

Phase 2 Not yet recruiting 39 enrolled StemCyte, Inc. StemCyte Taiwan Co., Ltd. · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

A Phase II, Randomized, Double-blind, Parallel, Placebo-controlled Study to Assess the Safety and Efficacy of Human Umbilical Cord Blood Infusion in Patients with Acute Ischemic Stroke

Timeline

Start
2025-09
Primary completion
2027-12
Completion
2028-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine Other

Indications